Clinical Trial Update: Program Cell Death Receptor 1 in Mycobacterium Avium Complex Lung Disease

View source ↗

Summary

A completed clinical trial investigated targeting the PD-1 pathway in Mycobacterium avium complex lung disease. The study was conducted by National Taiwan Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Lung Disease

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Mycobacterium Avium | Status: COMPLETED